Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darigabat in Chronic Low Back Pain
NCT02262754Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of darigabat in chronic low back pain (CLBP) (3 arms), sponsored by Pfizer. Primary endpoints: Daily Low Back Pain Intensity Score at 4 weeks and Treatment-Emergent Adverse Events and Serious Adverse Events at 56 days. Started Oct 2014; status: completed.
02
Drugs
darigabat
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02262754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262754.